Mohamed Haggag

•Developed business opportunities by identifying new markets and managing contract negotiations •Conducted market analysis and pricing for pharmaceutical tenders in the Middle East and Africa •Led sourcing and procurement, ensuring gross profit margins were met or exceeded. •Worked closely with clients to understand their needs and provided ongoing support, enhancing customer satisfaction and retention •Attended industry events, including the CPhI Convention.

•Conducted in-depth global market studies on anti-thyroid active pharmaceutical ingredients (APIs). •Led a global market study on animal-derived pharmaceuticals, utilizing market concentration measurement tools, Porter's Five Forces analysis, and IQVIA (IMS) raw sales data. The study provided strategic insights to help start-up and medium-sized pharmaceutical companies identify the most profitable markets, which in turn supported the development of market entry strategies and the expansion of product lines

• Represented the company, introduced and promoted a strong portfolio of neurosurgical products to customers within designated territories. • Played a vital role in helping neurosurgeons prescribe and recommend products appropriately to optimize performance and safety for patients. • Worked closely with Key Opinion Leaders (KOLs) and medical professionals to ensure effective product adoption. • Observed surgical operations, delivered product training to medical professionals, ensuring optimal product use.

•Increased product sales by 35% in 2011 through effective promotion and education of medical professionals on CPAP and BiPAP products for the treatment of sleep-related breathing disorders. •Managed both B2B and B2C relationships, ensuring customer satisfaction and product performance. •Conducted product training and provided technical support to healthcare professionals

•Promoted and introduced a strong portfolio of vascular and urological products by working closely with urologists and other medical professionals •Achieved significant success in launching the STATLOCK catheter stabilization device, guiding it from the introduction stage to peak growth, resulting in increased market share •Provided training and ongoing support to medical professionals to ensure optimal product use

•Prospected, segmented, and targeted potential markets for analgesic and anti-infl. products (e.g. DOLPHIN: diclofenac NA and potassium, AMOFLUX: antibiotic combination of amoxicillin and flucloxacillin) •Successfully launched and promoted the products •Developed relationships with healthcare professionals, including pharmacists and doctors, to drive product adoption and ensure optimal use •Exceeded sales goals by consistently achieving and surpassing monthly and annual sales targets

Master of Science international pharmacoeconomics and health economics

Bachlor of Veterinary Medicine